BusinessFDA Finally Addresses Synthetic Nicotine; Confirming Next Generation Labs’ Position that Synthetic Nicotine Is Not A Tobacco ProductBy Nasdaq OMXJan 20, 2017, 3:00 PM UTC
BusinessAdvanced Accelerator Applications Announces New England Journal of Medicine Publication of Lutathera® NETTER-1 Phase III ResultsBy Nasdaq OMXJan 12, 2017, 1:05 PM UTC
BusinessAkari Therapeutics Expands Clinical and Regulatory Teams with Industry VeteransBy Nasdaq OMXJan 4, 2017, 12:00 PM UTC
Business1WorldSync Partners With FDA Consultant Globizz to Offer Unified Product Information Solution for Japanese Healthcare MarketplaceBy Nasdaq OMXDec 19, 2016, 11:00 PM UTC
BusinessGreat Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens PanelBy Nasdaq OMXDec 19, 2016, 12:30 PM UTC
BusinessZomedica Opens Investigational New Animal Drug Application with FDA Center for Veterinary Medicine for Anti-diarrheal Medication ZM-007By Nasdaq OMXDec 19, 2016, 11:55 AM UTC
BusinessStatements From FDA in NICOPURE® vs. FDA Lawsuit Confirm Next Generation Labs’ TFN NICOTINE® Is Not A Tobacco ProductBy Nasdaq OMXDec 15, 2016, 4:30 PM UTC
BusinessBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDABy Nasdaq OMXNov 28, 2016, 11:00 AM UTC
